Advertisement

Embracing Uncertainty: The Value of Partial Identification in Public Health and Clinical Research

      Introduction

      This paper describes the methodology of partial identification and its applicability to empirical research in preventive medicine and public health.

      Methods

      The authors summarize findings from the methodologic literature on partial identification. The analysis was conducted in 2020–2021.

      Results

      The applicability of partial identification methods is demonstrated using 3 empirical examples drawn from published literature.

      Conclusions

      Partial identification methods are likely to be of considerable interest to clinicians and others engaged in preventive medicine and public health research.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Little RJ
        • D'Agostino R
        • Cohen ML
        • et al.
        The prevention and treatment of missing data in clinical trials.
        N Engl J Med. 2012; 367: 1355-1360https://doi.org/10.1056/NEJMsr1203730
        • Manski CF.
        Identification for Prediction and Decision.
        Harvard University Press, Cambridge, MA2007
        • Manski CF.
        Public Policy in an Uncertain World: Analysis and Decisions.
        Harvard University Press, Cambridge, MA2013
        • Bhattacharya J
        • Shaikh AM
        • Vytlacil E.
        Treatment effect bounds: an application to Swan-Ganz catheterization.
        J Econ. 2012; 168: 223-243https://doi.org/10.3386/w11263
        • Horowitz JL
        • Manski CF.
        Nonparametric analysis of randomized experiments with missing covariate and outcome data.
        J Am Stat Assoc. 2000; 95: 77-84https://doi.org/10.1080/01621459.2000.10473902
        • Manski CF.
        Diagnostic testing and treatment under ambiguity: using decision analysis to inform clinical practice.
        Proc Natl Acad Sci U S A. 2013; 110: 2064-2069https://doi.org/10.1073/pnas.1221405110
        • Manski CF.
        Credible ecological inference for medical decisions with personalized risk assessment.
        Quant Econ. 2018; 9: 541-569https://doi.org/10.3982/QE778
        • Manski CF.
        Patient Care Under Uncertainty.
        Princeton University Press, Princeton, NJ2019
        • Manski CF
        • Molinari F.
        Estimating the COVID-19 infection rate: anatomy of an inference problem.
        J Econom. 2021; 220: 181-192https://doi.org/10.1016/j.jeconom.2020.04.041
        • Millimet DL
        • Roy M.
        Partial identification of the long-run causal effect of food security on child health.
        Empir Econ. 2015; 48: 83-141https://doi.org/10.1007/s00181-014-0867-x
        • Mullahy J.
        Individual results may vary: inequality-probability bounds for some health-outcome treatment effects.
        J Health Econ. 2018; 61: 151-162https://doi.org/10.3386/w23603
        • Mullahy J.
        Discovering treatment effectiveness via median treatment effects-applications to COVID-19 clinical trials.
        Health Econ. March 5, 2021https://doi.org/10.1002/hec.4233 (In press)
        • Manski CF.
        Toward credible patient-centered meta-analysis.
        Epidemiology. 2020; 31: 345-352https://doi.org/10.1097/EDE.0000000000001178
        • Manski CF.
        Nonparametric bounds on treatment effects.
        AEA Pap Proc. 1990; 80: 319-323
        • Manski CF
        • Pepper JV.
        Monotone instrumental variables: with an application to the returns to schooling.
        Econometrica. 2000; 68: 997-1010https://doi.org/10.1111/1468-0262.00144
        • National Center for Health Statistics, Centers for Disease Control and Prevention
        Health, United States, 2018 (appendixes).
        National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD2019 (Accessed April 16, 2020)
        • National Center for Health Statistics, Centers for Disease Control and Prevention
        Table 31: vaccination coverage for selected diseases among children aged 19–35 months, by race, Hispanic origin, poverty level, and location of residence in metropolitan statistical area: United States, selected years 1998–2017.
        National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD2019 (Accessed April 16, 2020)
        • Materson BJ
        • Reda DJ
        • Cushman WC
        • et al.
        Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents [published correction appears in N Engl J Med. 1994;330(23):1689].
        N Engl J Med. 1993; 328: 914-921https://doi.org/10.1056/NEJM199304013281303
        • Manski CF.
        Reasonable patient care under uncertainty.
        Health Econ. 2018; 27: 1397-1421https://doi.org/10.1002/hec.3803